Open AccessEffects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism
Author(s) -
YeongHau H. Lien,
Arnold L. Silva,
David Whittman
Publication year - 2005
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh829
Subject(s) - cinacalcet , calcimimetic , medicine , secondary hyperparathyroidism , hyperparathyroidism , bone mineral , kidney disease , urology , primary hyperparathyroidism , endocrinology , parathyroid hormone , osteoporosis , calcium
Cinacalcet, a calcimimetic agent, is effective in treating both primary and secondary hyperparathyroidism. Because hyperparathyroidism induces mineralized bone loss, we investigated the effects of cinacalcet treatment on bone mineral density (BMD) in patients with secondary hyperparathyroidism due to chronic kidney disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom